VAIA
Virtus Alternative Investment Advisers Portfolio holdings
AUM
$6.71M
This Quarter Return
+15.08%
1 Year Return
+37.54%
3 Year Return
+43.39%
5 Year Return
–
10 Year Return
–
AUM
$6.71M
AUM Growth
+$6.71M
(+23%)
Cap. Flow
+$288K
Cap. Flow
% of AUM
4.29%
Top 10 Holdings %
Top 10 Hldgs %
47.64%
Holding
286
New
20
Increased
7
Reduced
247
Closed
6
Top Buys
| 1 |
DGL
Invesco DB Gold Fund
DGL
|
$1.64M |
| 2 |
Comcast
CMCSA
|
$159K |
| 3 |
Charter Communications
CHTR
|
$153K |
| 4 |
Delta Air Lines
DAL
|
$110K |
| 5 |
McDonald's
MCD
|
$89K |
Top Sells
| 1 |
Micron Technology
MU
|
$109K |
| 2 |
Watsco
WSO
|
$100K |
| 3 |
Merck
MRK
|
$66K |
| 4 |
Qualcomm
QCOM
|
$55.1K |
| 5 |
Broadcom
AVGO
|
$53.7K |
Sector Composition
| 1 | Industrials | 16.11% |
| 2 | Technology | 14.44% |
| 3 | Communication Services | 14.32% |
| 4 | Healthcare | 10.11% |
| 5 | Financials | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Church & Dwight Co
CHD
$22.7B
| $5K | 0.07% |
61
-60
| -50% | -$4.92K |
|
252
C.H. Robinson
CHRW
$15.2B
| $5K | 0.07% |
55
-53
| -49% | -$4.82K |
|
253
Clorox
CLX
$15B
| $5K | 0.07% |
26
-26
| -50% | -$5K |
|
254
Enanta Pharmaceuticals
ENTA
$189M
| $5K | 0.07% |
126
-122
| -49% | -$4.84K |
|
255
Flowers Foods
FLO
$3.09B
| $5K | 0.07% |
239
-231
| -49% | -$4.83K |
|
256
Fastly
FSLY
$1.08B
| $5K | 0.07% |
60
-57
| -49% | -$4.75K |
|
257
Hormel Foods
HRL
$13.9B
| $5K | 0.07% |
115
-112
| -49% | -$4.87K |
|
258
OrthoPediatrics
KIDS
$524M
| $5K | 0.07% |
132
-127
| -49% | -$4.81K |
|
259
Madrigal Pharmaceuticals
MDGL
$9.7B
| $5K | 0.07% |
45
-44
| -49% | -$4.89K |
|
260
Vail Resorts
MTN
$5.91B
| $5K | 0.07% |
+18
| New | +$5K |
|
261
Neurocrine Biosciences
NBIX
$13.5B
| $5K | 0.07% |
56
-55
| -50% | -$4.91K |
|
262
NovaGold Resources
NG
$2.73B
| $5K | 0.07% |
496
-479
| -49% | -$4.83K |
|
263
Penumbra
PEN
$10.5B
| $5K | 0.07% |
28
-26
| -48% | -$4.64K |
|
264
Royal Gold
RGLD
$11.9B
| $5K | 0.07% |
46
-44
| -49% | -$4.78K |
|
265
Relmada Therapeutics
RLMD
$48.8M
| $5K | 0.07% |
150
-145
| -49% | -$4.83K |
|
266
Schneider National
SNDR
$4.28B
| $5K | 0.07% |
224
-217
| -49% | -$4.84K |
|
267
Tandem Diabetes Care
TNDM
$834M
| $5K | 0.07% |
52
-50
| -49% | -$4.81K |
|
268
Viking Therapeutics
VKTX
$3.02B
| $5K | 0.07% |
843
-814
| -49% | -$4.83K |
|
269
Wingstop
WING
$9.01B
| $5K | 0.07% |
39
-179
| -82% | -$22.9K |
|
|
SILK
270
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $5K | 0.07% |
81
-79
| -49% | -$4.88K |
|
|
SGEN
271
DELISTED
Seagen Inc. Common Stock
SGEN
| $5K | 0.07% |
31
-30
| -49% | -$4.84K |
|
|
GBT
272
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $5K | 0.07% |
105
-101
| -49% | -$4.81K |
|
|
CTXS
273
DELISTED
Citrix Systems Inc
CTXS
| $5K | 0.07% |
41
-40
| -49% | -$4.88K |
|
|
LMNX
274
DELISTED
Luminex Corp
LMNX
| $5K | 0.07% |
228
-220
| -49% | -$4.83K |
|
275
Allogene Therapeutics
ALLO
$249M
| $4K | 0.06% |
156
-151
| -49% | -$3.87K |
|